Bliss GVS Pharma Ltd Q1 FY2024 consolidated PAT rises QoQ to Rs. 14.68 crores

Bliss GVS Pharma Limited has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 164.6344 crores during the period ended June 30, 2023 as compared to Rs. 187.7569 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 14.6851 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 3.3438 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 1.38 for the period ended June 30, 2023 as compared to Rs. 0.33 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 164.6344 crs	₹187.7569 crs	-12.32%
Net Profit	₹14.6851 crs	₹3.3438 crs	339.17%
EPS	₹1.38	₹0.33	318.18%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 164.6344 crores during the period ended June 30, 2023 as compared to Rs.195.6725 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.14.6851 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.25.7193 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.1.38 for the period ended June 30, 2023 as compared to Rs.2.44 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 164.6344 crs	₹195.6725 crs	-15.86%
Net Profit	₹14.6851 crs	₹25.7193 crs	-42.90%
EPS	₹1.38	₹2.44	-43.44%

Shares of Bliss GVS Pharma Limited was last trading in BSE at Rs. 98.57 as compared to the previous close of Rs. 99.41. The total number of shares traded during the day was 18033 in over 338 trades.

The stock hit an intraday high of Rs. 101.83 and intraday low of 97.00. The net turnover during the day was Rs. 1794488.00.

Source : Equity Bulls

Keywords

BlissGVSPharma Q1FY24 ResultUpdate